BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 26455479)

  • 21. Anti-allergic effect of bee venom in an allergic rhinitis mouse model.
    Shin SH; Kim YH; Kim JK; Park KK
    Biol Pharm Bull; 2014; 37(8):1295-300. PubMed ID: 25087951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival.
    Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Xaubet A; Bernal-Sprekelsen M; Picado C
    Clin Exp Allergy; 2006 Jan; 36(1):52-8. PubMed ID: 16393266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethno-medicinal study of Artemisia ordosica Krasch. (traditional Chinese/Mongolian medicine) extracts for the treatment of allergic rhinitis and nasosinusitis.
    Xiao B; Wang JH; Zhou CY; Chen JM; Zhang N; Zhao N; Han XY; Niu YX; Feng YB; Du GH
    J Ethnopharmacol; 2020 Feb; 248():112262. PubMed ID: 31585162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role for human nasal epithelial nuclear factor kappa B activation in histamine-induced mucin 5 subtype B overproduction.
    Wang W; Shao S; Wang S
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):264-70. PubMed ID: 26574733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent ameliorating effect of Hypoxia-inducible factor 1α (HIF-1α) antagonist YC-1 on combined allergic rhinitis and asthma syndrome (CARAS) in Rats.
    Wang X; Liu C; Wu L; Zhu S
    Eur J Pharmacol; 2016 Oct; 788():343-350. PubMed ID: 27498367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
    Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
    Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa.
    Fujikura T; Shimosawa T; Yakuo I
    J Allergy Clin Immunol; 2001 Jan; 107(1):123-8. PubMed ID: 11150001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis.
    Long R; Zhou Y; Huang J; Peng L; Meng L; Zhu S; Li J
    Inflamm Res; 2015 Apr; 64(3-4):213-23. PubMed ID: 25690567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xinqin exhibits the anti-allergic effect through the JAK2/STAT5 signaling pathway.
    Zhang Q; Xiong Y; Li GB; Tang Q; Cao M; Huang JB; Xing M; Hu CP; Gong Y; Wang QH; Gao N; Zhang R
    J Ethnopharmacol; 2016 Dec; 193():466-473. PubMed ID: 27666014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of inflammatory cytokine release from nasal epithelial cells of non-atopic non-rhinitic, allergic rhinitic and polyp subjects and effects of diesel exhaust particles in vitro.
    Ozturk AB; Bayraktar R; Gogebakan B; Mumbuc S; Bayram H
    Allergol Immunopathol (Madr); 2017; 45(5):473-481. PubMed ID: 28259510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
    Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
    Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Xingbi gel on leukotriene E4 and immunoglobulin E production and nasal eosinophilia in a guinea pig model for allergic rhinitis.
    Ai S; Zheng J; Chu KD; Zhang HS
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):99-106. PubMed ID: 26141030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
    Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
    Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Against NF-κB/thymic stromal lymphopoietin signaling pathway, catechin alleviates the inflammation in allergic rhinitis.
    Pan Z; Zhou Y; Luo X; Ruan Y; Zhou L; Wang Q; Yan YJ; Liu Q; Chen J
    Int Immunopharmacol; 2018 Aug; 61():241-248. PubMed ID: 29894863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
    Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
    Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of desloratadine on the TXB2 and leukotrienes levels in the nasal lavage fluid of allergic rhinitis animal model].
    Zhao Y; Van Hasselt CA; Woo K; Wong Y; Leung P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):365-7. PubMed ID: 16075993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desloratadine Ameliorates Olfactory Disorder and Suppresses AMPA Receptor GluA1 Expression in Allergic Rhinitis Rat.
    Li S; Zhang X; Li Z; Jiang X; Zhang N; Zhang J; Huang Y; Zhao H; Jiang Y; Li N
    Arch Immunol Ther Exp (Warsz); 2020 Feb; 68(1):6. PubMed ID: 32076842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
    Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
    Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
    J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.